Morgan Stanley Axogen, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Axogen, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,430,466 shares of AXGN stock, worth $45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,430,466

Previous 2,900,413 16.2%

Holding current value

$45 Million

Previous $40.7 Million 1.5%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$12.47 - $17.19 $5.86 Million - $8.08 Million	-469,947 Reduced 16.2%	2,430,466 $40.1 Million
Q3 2024 Nov 14, 2024	BUY	$7.52 - $14.69 $2.86 Million - $5.58 Million	380,025 Added 15.08%	2,900,413 $40.7 Million
Q2 2024 Oct 17, 2024	SELL	$5.67 - $8.06 $3.74 Million - $5.32 Million	-660,190 Reduced 20.76%	2,520,388 $18.2 Million
Q2 2024 Aug 14, 2024	SELL	$5.67 - $8.06 $3.74 Million - $5.32 Million	-660,190 Reduced 20.76%	2,520,388 $18.2 Million
Q1 2024 Oct 17, 2024	BUY	$6.63 - $10.69 $4.38 Million - $7.06 Million	660,190 Added 26.19%	3,180,578 $25.7 Million
Q1 2024 Aug 16, 2024	BUY	$6.63 - $10.69 $650,674 - $1.05 Million	98,141 Added 3.18%	3,180,578 $25.7 Million
Q1 2024 May 15, 2024	BUY	$6.63 - $10.69 $650,674 - $1.05 Million	98,141 Added 3.18%	3,180,578 $25.7 Million
Q4 2023 Aug 16, 2024	BUY	$3.61 - $7.76 $2.03 Million - $4.36 Million	562,049 Added 22.3%	3,082,437 $21.1 Million
Q4 2023 Feb 13, 2024	BUY	$3.61 - $7.76 $9.75 Million - $21 Million	2,702,067 Added 710.38%	3,082,437 $21.1 Million
Q3 2023 Nov 15, 2023	SELL	$4.68 - $9.26 $692,228 - $1.37 Million	-147,912 Reduced 28.0%	380,370 $1.9 Million
Q2 2023 Aug 14, 2023	SELL	$8.5 - $10.38 $611,796 - $747,110	-71,976 Reduced 11.99%	528,282 $4.82 Million
Q1 2023 May 15, 2023	SELL	$7.53 - $10.95 $103,680 - $150,770	-13,769 Reduced 2.24%	600,258 $5.67 Million
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $788,579 - $1.09 Million	83,536 Added 15.75%	614,027 $6.13 Million
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $1.02 Million - $1.53 Million	-124,919 Reduced 19.06%	530,491 $6.32 Million
Q2 2022 Oct 27, 2022	BUY	$6.99 - $10.0 $107,051 - $153,150	15,315 Added 2.39%	655,410 $5.37 Million
Q2 2022 Aug 15, 2022	BUY	$6.99 - $10.0 $107,051 - $153,150	15,315 Added 2.39%	655,410 $5.37 Million
Q1 2022 Oct 27, 2022	SELL	$7.26 - $10.7 $111,186 - $163,870	-15,315 Reduced 2.34%	640,095 $5.08 Million
Q1 2022 May 13, 2022	BUY	$7.26 - $10.7 $106,685 - $157,236	14,695 Added 2.35%	640,095 $5.08 Million
Q4 2021 Feb 14, 2022	BUY	$8.8 - $16.0 $4.76 Million - $8.66 Million	540,956 Added 640.61%	625,400 $5.86 Million
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $1.29 Million - $1.83 Million	84,444 New	84,444 $1.33 Million

Others Institutions Holding AXGN

# of Institutions

179

Shares Held

36.2M

Call Options Held

82.6K

Put Options Held

1.1K

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $782M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account